Michael Rivner


Michael Rivner


Academic Appointment(s)

Medical College of Georgia
Department of Neurology

Emeritus Faculty

The Graduate School

Medical College of Georgia
Department of Neuroscience and Regenerative Medicine

Department of The Graduate School


I am a specialist in Neuromuscular diseases. I established and run the ALS clinic. I have research grants in Myasthenia Gravis and ALS. I run the EMG lab at AUHealth. I also have an interest in botulinum toxins.

  • (706) 721-2681
  • (706) 721-8701
  • BP 4390


  • MD, Medicine Emory University, 1978

  • BA, Psychology, General Duke University, 1972

  • BA, Zoology/Animal Biology Duke University, 1972


  • PHY GA Composite Medical Brd, 1979

  • BLS 2014

Courses Taught Most Recent Academic Year

  • NEUR 5000

    Basic Clkshp in Neurology
  • RNEU 5000


Teaching Interests

EMG, ALS, Myasthenia Gravis, Neuromuscular diseases, botulinum toxin


Selected Recent Publications

  • Induction of anti-agrin antibodies causes myasthenia gravis in mice, 2018
    Journal Article, Academic Journal
  • Agrin and LRP4 antibodies in Amyotrophic Lateral Sclerosis Patients, 2017
    Journal Article, Academic Journal
  • Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study, 2017
    Journal Article, Academic Journal
  • Phase IIA Trial of Fingolimod for ALS Demonstrates Acceptable Acute Safety and Tolerability, 2017
    Journal Article, Academic Journal
  • Screening for llipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis, 2017
    Journal Article, Academic Journal

Research Interests

Myasthenia Gravis
Botulinum Toxins

Professional Service

  • ALS Clinic 2007 - 2018

    Role: Director
  • EMG Lab 1983 - 2018

    Role: Director